Merck KGaA receives Investment Bank Analyst Rating Update
- ByInvesting.com-
By Geoffrey Smith Investing.com -- German stocks are back in a bull market. The benchmark DAX index rose nearly 1% on Monday after the European Commission gave Berlin permission to...
By Scott Kanowsky Investing.com -- Shares in Merck KGaA (ETR:MRCG) rose in late afternoon trading on Thursday, erasing earlier losses, after the German science and technology...
Looking to diversify across asset classes, investment styles, or regions? Multifactor exchange-traded funds are worth considering. There are around 300 multifactor exchange-traded...
by Clement Thibault Mylan (NASDAQ:MYL), the global manufacturer and distributor of generic, branded generic and specialty pharmaceuticals will release its Q3 2016 earnings report...
The story of the unfolding Q4 earnings season is essentially a commentary on three inter-related factors – oil, the U.S. dollar and global economic growth. Oil aside, the...
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
| Average | 209.03 (+9.78% Upside) |
| High | 250.00 |
| Low | 158.00 |
| Price | 190.40 |
| No. of Analysts | 17 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Strong Sell | Strong Sell | Buy | Strong Buy |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Neutral | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 248.15 | 249.83 | 246.83 | +0.15 | +0.06% | 25.98M | NASDAQ | |||
| 177.88 | 180.68 | 161.17 | +17.61 | +10.99% | 304.01M | NASDAQ | |||
| 28.16 | 28.24 | 26.78 | -1.93 | -6.41% | 147.99M | NASDAQ | |||
| 81.32 | 81.40 | 80.48 | +0.73 | +0.91% | 621.19K | NYSE | |||
| 9.50 | 9.50 | 9.48 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 51.86 | 52.19 | 51.66 | -0.33 | -0.63% | 18.10M | NYSE | |||
| 97.28 | 98.11 | 96.69 | -0.32 | -0.33% | 30.23K | NASDAQ | |||
| 115.25 | 115.78 | 113.46 | +1.70 | +1.50% | 3.65M | NYSE | |||
| 31.44 | 32.46 | 31.40 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 24.46 | 24.68 | 24.25 | -0.04 | -0.16% | 70.12K | NYSE | |||
| 12.87 | 17.81 | 8.91 | +3.87 | +43.00% | 208.15M | NASDAQ | |||
| 38.02 | 38.46 | 37.91 | -0.03 | -0.08% | 932.44K | NYSE | |||
| 15.39 | 15.65 | 15.30 | -0.16 | -1.03% | 422.47K | NASDAQ | |||
| 82.34 | 83.48 | 82.24 | -0.89 | -1.07% | 500.79K | NYSE | |||
| 115.94 | 117.12 | 108.73 | +6.52 | +5.96% | 9.55M | NASDAQ |